HCM
IBIO icon

Harvey Capital Management’s iBio IBIO Stock Holding History

Harvey Capital Management’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-150
Closed -$78K – 79
2020
Q4 		$78K Buy
150
+70
+88% +$57K 0.03% 73
2020
Q3 		$81K Buy
80
+10
+14% +$14.5K 0.04% 75
2020
Q2 		$77K Buy
+70
New +$45.8K 0.04% 73

Other funds holding IBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Harvey Capital Management's IBIO Position: Q1 2021 in Review

Harvey Capital Management sold out of iBio (IBIO) in Q1 2021, closing a stake of 150 shares — an estimated $78K sold.

Harvey Capital Management first reported a position in IBIO in Q2 2020 and held it in 3 quarters. The position peaked at $81K in Q3 2020. 91 funds tracked by Wall St. Rank hold IBIO as of Q1 2021.

  • Harvey Capital Management reported no remaining iBio position as of Q1 2021 after selling out during the quarter.
  • Harvey Capital Management sold 150 iBio shares in Q1 2021, an estimated $78K.
  • Harvey Capital Management first reported a position in iBio in Q2 2020 and held it in 3 quarters.
  • Harvey Capital Management's iBio position peaked at $81K in Q3 2020.
  • 91 funds tracked by Wall St. Rank held iBio as of Q1 2021.

Based on Harvey Capital Management's 13F filing for Q1 2021, filed 7 May 2021.